Author: Bell J.
Publisher: Adis International
ISSN: 0114-5916
Source: Drug Safety, Vol.22, Iss.3, 2000-03, pp. : 179-190
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
A Risk-Benefit Assessment of Sildenafil in the Treatment of Erectile Dysfunction
By Vitezic D.
Drug Safety, Vol. 24, Iss. 4, 2001-01 ,pp. :
A Risk-Benefit Assessment of Alendronate in the Treatment of Involutional Osteoporosis
Drug Safety, Vol. 19, Iss. 2, 1998-08 ,pp. :